Science.Online
Publisher and Institutes
Akademie Verlag
Deutsches Institut für Urbanistik
Oldenbourg Wissenschaftsverlag
Walter de Gruyter
Schattauer
You are here: Home :: Keyword index :: nad bis par :: nutritional status - obligation to report obesity

Items for "obesity"

Polymorphism A36G of the tumor necrosis factor receptor 1 gene is associated with PAI-1 levels in obese women

The tumor necrosis factor (TNF) pathway may be implicated in etiopathogenesis of PAI-1 overexpression during obesity...

Keywords: obesity, metabolic syndrome, inflammation, TNFR1, PAI-1

01/2007 | Thrombosis and Haemostasis, Schattauer
Behavioral Interventions and the Role of Television in the Growing Epidemic of Adolescent Obesity Data from the 2001 Youth Risk Behavioral Survey

OBJECTIVE: To test television exposures contribution to overweight (BMI > 95th percentile /age) status in 11.3% of 2001 YRBS respondents, when controlling for moderate/vigorous activity, and eating habits. METHODS: Controlling for age, ethnicity, smoking, moderate/vigorous activity, and diet habits, gender-specific SUDAAN models estimate likelihood (O.R.) for overweight in teens watching 2+ hours of TV/day. RESULTS: TV exposure independently increases odds of overweight by 50% for both genders (boys: OR 1.5 [1.2-1.8]; girls: OR 1.6 [1.2-2.0]), when other covariates are controlled...

Keywords: Adolescents, obesity, physical activity, television, diet

01/2005 | Methods of Information in Medicine, Schattauer
Increased cardiovascular risk markers in obesity are associated with body adiposity: Role of leptin

Epidemiological studies have shown that obesity is associated with increased blood concentrations of proinflammatory factors and markers of endothelial dysfunction such as fibrinogen, C-reactive protein (CRP), and vonWillebrand factor (vWF)...

Keywords: obesity, adipose tissue, inflammation, leptin, insulin resistance

06/2006 | Thrombosis and Haemostasis, Schattauer
Overexpression of tissue inhibitor of matrix metalloproteinases-1 (TIMP-1) in mice does not affect adipogenesis or adipose tissue development

In order to evaluate a potential functional role of tissue inhibitor of matrix metalloproteinases-1 (TIMP-1) in development of obesity, we studied the effect of overexpression of human TIMP-1 (hTIMP-1) in C57Bl/6J mice in vivo and in 3T3-F442A preadipocytes in vitro...

Keywords: Tissue inhibitor of metalloproteinase-1,TIMP-1, obesity, adipose tissue, adipogenesis

06/2006 | Thrombosis and Haemostasis, Schattauer
Tiplaxtinin impairs nutritionally induced obesity in mice

To investigate the effect of tiplaxtinin, designed as a synthetic inhibitor of plasminogen activator inhibitor-1 (PAI-1), on obesity, male C57Bl/6 mice (13-14 weeks old) were kept on a high-fat diet (20.1 kJ/g) for four weeks without or with addition of tiplaxtinin (PAI-039) at a dose of 2 mg/g food...

Keywords: PAI-1, obesity, adipose tissue, glucose tolerance, insulin sensitivity

12/2006 | Thrombosis and Haemostasis, Schattauer
Sex-specific, independent associations of insulin resistance with erythrocyte sedimentation rate in apparently healthy subjects

Insulin resistance and erythrocyte sedimentation rate (ESR, a non-specific marker of inflammation) are known risk factors for cardiovascular disease...

Keywords: Diabetes mellitus, obesity, inflammation, insulin sensitivity, erythrocyte sedimentation rate

00/0000 | Thrombosis and Haemostasis, Schattauer
Increased glycation of hemoglobin and plasma proteins in normotensive, non-diabetic obese Indian subjects: putative role of lipid peroxides

Background: Glycation and lipid peroxidation are spontaneous reactions believed to contribute to the pathogenesis of many clinical disorders...

Keywords: fructosamine, glycated hemoglobin, glycation, lipid peroxides, obesity

08/2007 | Clinical Chemical Laboratory Medicine, Walter de Gruyter
Apolipoprotein A-V gene polymorphisms in subjects with metabolic syndrome

Background: Genetic variation at the apolipoprotein A-V locus, recently discovered proximal to the APOA1/C3/A4 gene cluster, is associated with elevated triglyceride concentrations, a risk factor for atherosclerosis.

Methods: The goal of our study was to determine the association of two apolipoprotein A-V (APOA5) gene polymorphisms in a group of urban Romanian subjects with the prevalence of the metabolic syndrome...

Keywords: apolipoprotein A-V, gene polymorphism, metabolic syndrome, obesity

09/2007 | Clinical Chemical Laboratory Medicine, Walter de Gruyter
Evaluation of genetic predisposition to insulin resistance by nutrient-induced insulin output ratio (NIOR)

Background: New tools to identify genotype-phenotype interactions need to be described and implemented...

Keywords: gene polymorphisms, individualized nutrition, insulin resistance, metabolic syndrome, obesity, prognostic marker

09/2007 | Clinical Chemical Laboratory Medicine, Walter de Gruyter
Pro12Ala polymorphism of the peroxisome proliferator-activated receptor-&ggr;2 (PPAR&ggr;-2) gene is associated with greater insulin sensitivity and decreased risk of type 2 diabetes in an Iranian population

Background: The Pro12Ala polymorphism of the peroxisome proliferator-activated receptor-&ggr;2 (PPAR&ggr;-2) gene has been variably associated with insulin resistance, obesity and type 2 diabetes in several populations...

Keywords: insulin resistance, Iranian population, obesity, peroxisome proliferator-activated receptor-2 (PPAR-2), Pro12Ala, type 2 diabetes

04/2007 | Clinical Chemical Laboratory Medicine, Walter de Gruyter
The genetic polymorphisms of β3-adrenergic receptor (AR) Trp64Arg and β2-AR Gln27Glu are associated with obesity in Chinese male hypertensive patients

Background: Genetic polymorphisms of β3-adrenergic receptor (AR) Trp64Arg and β2-AR Gln27Glu may result in significant change in the functions of these receptors...

Keywords: 2-adrenergic receptor, 3-adrenergic receptor, genetic polymorphism, haplotype, obesity

04/2007 | Clinical Chemical Laboratory Medicine, Walter de Gruyter
Within-subject variation of plasma resistin levels over a 1-year period

Background: Resistin, a recently discovered hormone, is purportedly involved in metabolic and inflammatory processes in humans and may thus be an important marker to assess disease risk in large-scale epidemiological studies.

Methods: We assessed the reliability of human resistin levels in 63 men and 51 women aged 35–67 years with repeated measurements of resistin over a period of 1 year...

Keywords: biomarker, inflammation, obesity, reliability, risk factor

07/2007 | Clinical Chemical Laboratory Medicine, Walter de Gruyter
Butyrylcholinesterase activity and metabolic syndrome in obese patients

Total butyrylcholinesterase activity (EC 3.1.1.8) was previously suggested as a marker for metabolic syndrome...

Keywords: BCHE and CHE2 loci, C 4/5 and C OF bands, metabolic syndrome, obesity, serum cholinesterase

03/2005 | Clinical Chemical Laboratory Medicine, Walter de Gruyter
Genotypes, obesity and type 2 diabetes – can genetic information motivate weight loss? A review

The current worldwide prevalence of type 2 diabetes (T2D) was estimated to be 2.8% in 2000, but it is predicted to increase to epidemic proportions in the coming decades, primarily due to lifestyle changes, particularly obesity...

Keywords: genetic testing, motivation, obesity, type 2 diabetes

03/2007 | Clinical Chemical Laboratory Medicine, Walter de Gruyter
The Gene-Diet Attica Investigation on childhood obesity (GENDAI): overview of the study design

Background: There is limited evidence on the role of genetic and environmental factors in the etiology of childhood obesity, a major health problem worldwide.

Methods: The Gene-Diet Attica Investigation on childhood obesity (GENDAI) evaluates the contributions to and pivotal interactions of genetic, dietary and physical activity variables on children's weight...

Keywords: children, diet, gene, obesity, physical activity

03/2007 | Clinical Chemical Laboratory Medicine, Walter de Gruyter
Emerging role of cathepsin S in obesity and its associated diseases

Obesity is thought to be a major determinant in the development of cardiovascular diseases, but the mechanisms whereby enlarged adipose tissue affects vascular function remain poorly defined...

Keywords: atherosclerosis, cathepsin S, obesity

03/2007 | Clinical Chemical Laboratory Medicine, Walter de Gruyter
Maternal obesity and complications during pregnancy

Obesity has become a major health problem all over the world and during pregnancy is associated with an increased risk of complications, including gestational diabetes, preeclampsia, and delivery complications such as macrosomia, shoulder dystocia and higher rates of cesarean sections and infections...

Keywords: Fetal outcome, obesity, pregnancy, preeclampsia

03/2005 | Journal of Perinatal Medicine, Walter de Gruyter
The combined effect of maternal smoking and obesity on the risk of preeclampsia

Aims: Cigarette smoking during pregnancy is associated with a lower risk of preeclampsia, whereas obesity increases the risk of preeclampsia...

Keywords: eclampsia, hypertension, obesity, overweight, pre-eclampsia, pregnancy, smoking

02/2007 | Journal of Perinatal Medicine, Walter de Gruyter
Adiponektin, ein Adipokin mit großem Potenzial für Diagnostik und Therapie des metabolischen Syndroms und assoziierter kardiovaskulärer Erkrankungen / Adiponectin, an adipokine as a promising target for diagnosis and therapy of the metabolic syndrome and

Zusammenfassung

Das Fettgewebe wurde lange Zeit nur als Energiespeicher angesehen. Untersuchungen der letzten Jahre identifizierten jedoch das Fettgewebe als ein hochaktives metabolisches und endokrines Organ...

Keywords: Adipokine, Adiponektin, Fettgewebe, Übergewicht, adipokines, adiponectin, adipose tissue, obesity

08/2006 | LaboratoriumsMedizin, Walter de Gruyter
Sub-chronic administration of the 11?-HSD1 inhibitor, carbenoxolone, improves glucose tolerance and insulin sensitivity in mice with diet-induced obesity

We have examined the metabolic effects of daily administration of carbenoxolone (CBX), a naturally occurring 11?-hydroxysteroid dehydrogenase (11?-HSD1) inhibitor, in mice with high fat diet-induced insulin resistance and obesity...

Keywords: carbenoxolone (CBX), glucose tolerance, 11?-hydroxysteroid dehydrogenase type 1 (11?-HSD1), insulin sensitivity, obesity, type 2 diabetes

04/2008 | Biological Chemistry, Walter de Gruyter
Adiponectin in severe preeclampsia

Aims: Adiponectin is an adipokine with insulin-sensitizing, anti-atherogenic, anti-inflammatory and angiogenic properties...

Keywords: adiponectin, Doppler, obesity, preeclampsia, pregnancy, uterine artery

12/2007 | Journal of Perinatal Medicine, Walter de Gruyter
Resistin: a hormone which induces insulin resistance is increased in normal pregnancy

Aims: Resistin, a newly discovered adipokine, is thought to play a key role in the regulation of insulin resistance...

Keywords: adipokines, nomogram, obesity, pregnancy, resistin

12/2007 | Journal of Perinatal Medicine, Walter de Gruyter
Plasma adiponectin concentrations in non-pregnant, normal and overweight pregnant women

Aims: Adiponectin is an adipokine that has anti-diabetic, anti-atherogenic, anti-inflammatory and angiogenic properties...

Keywords: adipokines, adiponectin, nomogram, obesity, pregnancy

12/2007 | Journal of Perinatal Medicine, Walter de Gruyter
CD36 polymorphism and its relationship with body mass index and coronary artery disease in a Korean population

Background: CD36 is a multifunctional membrane receptor and a cell-adhesion molecule that is expressed in platelets, monocytes/macrophages, microvascular endothelial cells, cardiac monocytes and adipocytes...

Keywords: Body mass index, CD36, coronary artery disease, obesity, polymorphisms

10/2007 | Clinical Chemical Laboratory Medicine, Walter de Gruyter
Apolipoprotein E polymorphism – a risk factor for metabolic syndrome

Background: Metabolic syndrome is closely related to several disturbances in lipid and lipoprotein metabolism...

Keywords: apolipoprotein E genotypes, coronary heart disease, dyslipidemia, metabolic syndrome, obesity

09/2007 | Clinical Chemical Laboratory Medicine, Walter de Gruyter